USFDA inspects Granules India’s Gagillapur facility

17 Mar 2015 Evaluate

Granules India’s Gagillapur facility has been inspected by US Food and Drug Administration (USFDA) last week and the inspection concluded with no observations. The inspection was triggered by one of the applicant’s ANDA filing.

Granules India is a fast growing pharmaceutical manufacturing company with world class facilities and is committed to manufacturing excellence, quality and customer service. The Company produces Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) for quality conscious customers in the regulated and semi-regulated markets.

Granules India Share Price

580.85 21.35 (3.82%)
10-Mar-2026 15:52 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1813.00
Dr. Reddys Lab 1315.70
Cipla 1333.10
Zydus Lifesciences 923.95
Lupin 2344.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×